Therefore, a more biologically informative and clinically relevant oligodendroglioma model would be introducing the 1p/19q co-deletion and other coordinating mutations (eg, TERT promoter, and FUBP1 or CIC) in IDH mutant cells of the oligodendrocytic lineage. The gene discussed is TERT; the disease is oligodendroglioma.